Search Results
Advertisement
Your search for SYED A. ABUTALIB, MD AND MATTHEW J. PIANKO, MD matches 2 pages
Showing 1 - 2Navigating Early Relapse in Multiple Myeloma: New Evidence from the 2026 ASCO and EHA Congresses
“The future of cancer therapy lies in rational combinations that harness the immune system while preserving patient quality of life.” —Vincent T. DeVita, MD The treatment landscape for relapsed/refractory (R/R) multiple myeloma continues to evolve rapidly as T-cell–redirecting bispecific...
ASH 2025: Highlights in Relapsed/Refractory Multiple Myeloma
“Dripping water hollows out stone, not through force but through persistence.” – Ovid The 2025 American Society of Hematology (ASH) Annual Meeting & Exposition delivered multiple practice-changing data sets surrounding T-cell–redirecting therapies in relapsed or refractory multiple myeloma....
Advertisement
Advertisement
Aug
Today In Oncology18
Advertisement
© 2026 HSP News Service, L.L.C.
